Absorption of hyaluronan applied to the surface of intact skin

被引:69
作者
Brown, TJ
Alcorn, D
Fraser, JRE
机构
[1] Monash Univ, Dept Mol Biol & Biochem, Melbourne, Vic 3168, Australia
[2] Univ Melbourne, Dept Anat, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Vet Sci, Melbourne, Vic, Australia
关键词
glycosaminoglycans; metabolism; transdermal drug delivery;
D O I
10.1046/j.1523-1747.1999.00745.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Hyaluronan has recently been introduced as a vehicle for topical application of drugs to the skin. We sought to determine whether hyaluronan acts solely as a hydrophilic reservoir on the surface of intact skin or might partly penetrate it. Drug-free hyaluronan gels were applied to the intact skin of hairless mice and human forearm in situ, with and without [H-3] hyaluronan. [H-3]hyaluronan was shown by autoradiography to disseminate through all layers of intact skin in mouse and human, reaching the dermis within 30 min of application in mice. Cellular uptake of [H-3]hyaluronan was observed in the deeper layers of epidermis, dermis, and in lymphatic endothelium. Absorption through skin was confirmed in mice by chromatographic analysis of blood, urine, and extracts from skin and liver, which identified H-3 as intact hyaluronan and its metabolites, free acetate and water, Hyaluronan absorption was similarly demonstrated without polyethylene glycol, which is usually included in the topical formulation. [H-3]hyaluronan absorption was not restricted to its smaller polymers as demonstrated by the recovery of polymers of (360-400 kDa) from both blood and skin. This finding suggests that its passage through epidermis does not rely on passive diffusion but may be facilitated by active transport. This study establishes that hyaluronan is absorbed from the surface of the skin and passes rapidly through epidermis, which may allow associated drugs to be carried in relatively high concentration at least as far as the deeper layers of the dermis.
引用
收藏
页码:740 / 746
页数:7
相关论文
共 22 条
[11]  
Laurent TC, 1970, CHEM MOL BIOL INTERC, P703
[12]  
Moore AR, 1995, INT J TISSUE REACT, V17, P153
[13]  
Ogiso T, 1996, BIOL PHARM BULL, V19, P1049
[14]  
OGISO T, 1995, BIOL PHARM BULL, V18, P1566
[15]   REMOVAL RATE OF [H-3] HYALURONAN INJECTED SUBCUTANEOUSLY IN RABBITS [J].
REED, RK ;
LAURENT, UBG ;
FRASER, JRE ;
LAURENT, TC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (02) :H532-H535
[16]  
SCOTT JE, 1989, CIBA F SYMP, V143, P6
[17]   TRANSPORT OF BIOLOGICALLY-ACTIVE INTERFERON-GAMMA ACROSS HUMAN SKIN IN-VITRO [J].
SHORT, SM ;
RUBAS, W ;
PAASCH, BD ;
MRSNY, RJ .
PHARMACEUTICAL RESEARCH, 1995, 12 (08) :1140-1145
[18]   PERMEABILITY OF MUSCLE CAPILLARIES TO SMALL HEME-PEPTIDES - EVIDENCE FOR EXISTENCE OF PATENT TRANSENDOTHELIAL CHANNELS [J].
SIMIONESCU, N ;
SIMIONESCU, M ;
PALADE, GE .
JOURNAL OF CELL BIOLOGY, 1975, 64 (03) :586-607
[19]  
STUTTGEN G, 1990, ARZNEIMITTEL-FORSCH, V40-1, P484
[20]   DEGRADATION OF NEWLY SYNTHESIZED HIGH MOLECULAR MASS HYALURONAN IN THE EPIDERMAL AND DERMAL COMPARTMENTS OF HUMAN SKIN IN ORGAN-CULTURE [J].
TAMMI, R ;
SAAMANEN, AM ;
MAIBACH, HI ;
TAMMI, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (01) :126-130